Biocept

$0.8801
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0321 (-3.52%) As of 2:40 PM EDT today
-$0.0321 (-3.52%) Today

Why Robinhood?

You can buy or sell Biocept and other stocks, options, ETFs, and crypto commission-free!

About BIOC

Biocept, Inc. Common Stock, also called Biocept, is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. Read More It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Employees
87
Headquarters
San Diego, California
Founded
1997
Market Cap
21.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
338.17K
High Today
$0.9099
Low Today
$0.8711
Open Price
$0.904
Volume
207.90K
52 Week High
$3.72
52 Week Low
$0.658

Collections

BIOC Earnings

-$3.30
-$2.23
-$1.16
-$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.